Latest News and Updates from PORTON - Your Trusted CDMO Partner

CN
Newsroom


A Customer-centric, Innovative
and Reliable CDMO with Global Solutions

1-22 of 192 result

News Aug 27, 2024

Connect with Porton at CPhI Europe 2024 @ Booth 5C17

Early bird registration will close on September 5th, 2024

News Aug 13, 2024

The 5th Pharma Crystallization Summit is coming this September!

Early bird registration will close on September 5th, 2024

News Jul 19, 2024

Porton Passed FDA cGMP Inspection with No Action Indicated(NAI)

STRATEGIC EXPANSIONS FOR CUSTOMER-CENTRIC & GLOBAL SOLUTIONS

NewslettersJul 07, 2024

Porton Newsletter | Q2 2024 Recap

Porton Pharma Solutions Embark on The Next Frontier in Mengeš, Slovenia. Announcement of New GMP HPAPI Lab and Integrated DS-DP Facilities at Porton J-STAR. Porton can provide one-stop CDMO services from PCC to IND and GMP clinical supply of ADC drugs for global pharmaceutical companies.

News Jul 05, 2024

Technology-Driven | Porton's Crystallization Team and Genentech Jointly Published Breakthrough Results in 《Pharmaceutical Research》

STRATEGIC EXPANSIONS FOR CUSTOMER-CENTRIC & GLOBAL SOLUTIONS

News Jun 29, 2024

Porton Experts Invited to Participate in the University of Perugia Master PRO-API Program, Aiding in the Training of Green Process Chemistry Professionals

STRATEGIC EXPANSIONS FOR CUSTOMER-CENTRIC & GLOBAL SOLUTIONS

News Jun 28, 2024

Porton J-STAR and Enabling Technologies Consortium Collaboration on Co-processing Platform Technology Development

STRATEGIC EXPANSIONS FOR CUSTOMER-CENTRIC & GLOBAL SOLUTIONS

Porton will be Participating in Biotech Outsourcing Strategies Events this June

News Jun 06, 2024

Porton will be Participating in Biotech Outsourcing Strategies Events this June

STRATEGIC EXPANSIONS FOR CUSTOMER-CENTRIC & GLOBAL SOLUTIONS

News May 23, 2024

Porton Pharma Solutions embark on the next frontier in Mengeš, Slovenia

On May 22, 2024 Opening ceremony of the state-of-the-art research and development laboratories for active pharmaceutical ingredients, small molecules, of Porton in Mengeš

Become part of Porton' s community to access personalized insights and resources.
Subscribe To Our Mailing List
Porton requires your contact information to reach out to you about our products and services. You can unsubscribe from these communications at any time. For details on how to unsubscribe and our commitment to protecting your privacy, please review ourLegal Disclaimer terms and Porton Privacy.

ⓒ 2025 PORTON Legal Notices | Porton Privacy

This website provides information on products tailored for a diverse audience and may include product details or information that are not readily accessible or valid in your country. Please note that we do not accept any responsibility for accessing such information in a manner that may violate any legal processes, regulations, registrations, or usage guidelines in your country of origin.

Become part of Porton' s community to access personalized insights and resources.
Submit
By clicking “Submit” you agree to our Legal Disclaimer terms and conditions and the Porton Privacy and Cookies Policy.

ⓒ 2025 PORTON Legal Notices | Porton Privacy

US: (609) 860-1300
CN: (86) 23-8608-3200